UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: Mechanisms and therapeutic opportunities

Journal of molecular and cellular cardiology, 2011-04, Vol.50 (4), p.613-620

2011

Link zum Volltext

Verfügbarkeit prüfen

Piezo2 is not an indispensable mechanosensor in murine cardiomyocytes

Scientific reports, 2022-05, Vol.12 (1), p.8193-8193, Article 8193

2022

Link zum Volltext

Verfügbarkeit prüfen

The W101C KCNJ5 Mutation Induces Slower Pacing by Constitutively Active GIRK Channels in hiPSC-Derived Cardiomyocytes

International journal of molecular sciences, 2023-10, Vol.24 (20), p.15290

2023

Link zum Volltext

Verfügbarkeit prüfen

Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy

EMBO molecular medicine, 2019-12, Vol.11 (12), p.e11115-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice

Nature communications, 2014-12, Vol.5 (1), p.5515, Article 5515

2014

Link zum Volltext

Verfügbarkeit prüfen

Comparison of the effects of a truncating and a missense MYBPC3 mutation on contractile parameters of engineered heart tissue

Journal of molecular and cellular cardiology, 2016-08, Vol.97, p.82-92

2016

Link zum Volltext

Verfügbarkeit prüfen

Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A)

Stem cell research, 2024-08, Vol.78, p.103446, Article 103446

2024

Link zum Volltext

Verfügbarkeit prüfen

Endothelin‐1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy–Induced Pluripotent Stem Cell–Derived Cardiomyocytes

Journal of the American Heart Association, 2014-11, Vol.3 (6), p.e001263-n/a

2014

Link zum Volltext

Verfügbarkeit prüfen

Nonsense-Mediated mRNA Decay and Ubiquitin–Proteasome System Regulate Cardiac Myosin-Binding Protein C Mutant Levels in Cardiomyopathic Mice

Circulation research, 2009-07, Vol.105 (3), p.239-248

2009

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes

Molecular therapy. Nucleic acids, 2017-06, Vol.7 (C), p.475-486

2017

Link zum Volltext

Verfügbarkeit prüfen

MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction

Pflügers Archiv, 2014-02, Vol.466 (2), p.215-223

2014

Link zum Volltext

Verfügbarkeit prüfen

Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic Cardiomyopathy

Journal of cardiac failure, 2016-10, Vol.22 (10), p.845-850

2016

Link zum Volltext

Verfügbarkeit prüfen

Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy

EMBO molecular medicine, 2022-08, Vol.14 (8), p.e16423-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue

Frontiers in physiology, 2019-03, Vol.10, p.239-239

2019

Link zum Volltext

Verfügbarkeit prüfen

Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms

Cardiovascular research, 2010-01, Vol.85 (2), p.357-366

2010

Link zum Volltext

Verfügbarkeit prüfen

Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy

Stem cell research, 2021-08, Vol.55, p.102489-102489, Article 102489

2021

Link zum Volltext

Verfügbarkeit prüfen

Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice

Journal of muscle research and cell motility, 2012-05, Vol.33 (1), p.5-15

2012

Link zum Volltext

Verfügbarkeit prüfen

ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes

Cells (Basel, Switzerland), 2022-09, Vol.11 (17), p.2745

2022

Link zum Volltext

Verfügbarkeit prüfen

Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology

Gene, 2015-12, Vol.573 (2), p.188-197

2015

Link zum Volltext

Verfügbarkeit prüfen

Gene therapy strategies in the treatment of hypertrophic cardiomyopathy

Pflügers Archiv, 2019-05, Vol.471 (5), p.807-815

2019

Link zum Volltext

Verfügbarkeit prüfen

Effects of Chronic Atrial Fibrillation on Active and Passive Force Generation in Human Atrial Myofibrils

Circulation research, 2010-07, Vol.107 (1), p.144-152

2010

Link zum Volltext

Verfügbarkeit prüfen

Repair of Mybpc3 mRNA by 5′-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy

Molecular therapy. Nucleic acids, 2013-07, Vol.2 (7), p.e102-e102, Article e102

2013

Link zum Volltext

Verfügbarkeit prüfen

BSE-associated prion-amyloid cardiomyopathy in primates

Emerging infectious diseases, 2013-06, Vol.19 (6), p.985-988

2013

Link zum Volltext

Verfügbarkeit prüfen

Local Chromatin Mobility is Independent of Transcriptional Activity

Cell cycle (Georgetown, Tex.), 2006-09, Vol.5 (17), p.1989-1995

2006

Link zum Volltext

Verfügbarkeit prüfen

The W101C IKCNJ5/I Mutation Induces Slower Pacing by Constitutively Active GIRK Channels in hiPSC-Derived Cardiomyocytes

International journal of molecular sciences, 2023-10, Vol.24 (20)

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(62)

Sprache

Englisch
(62)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(47)
Life Sciences & Biomedicine
(44)
Humans
(23)
Animals
(21)
Cell Biology
(15)
Mutation
(15)
Cardiomyopathy
(13)
Cardiac & Cardiovascular Systems
(11)
Cardiovascular System & Cardiology
(11)
Male
(11)
Carrier Proteins - Genetics
(10)
Cardiomyocytes
(9)
Carrier Proteins - Metabolism
(9)
Mice
(9)
Cardiomyopathy, Hypertrophic - Genetics
(8)
Female
(8)
Hypertrophic Cardiomyopathy
(8)
Hypertrophy
(8)
Gene Expression
(7)
Medicine, Research & Experimental
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: Mechanisms and therapeutic opportunities

Piezo2 is not an indispensable mechanosensor in murine cardiomyocytes

The W101C KCNJ5 Mutation Induces Slower Pacing by Constitutively Active GIRK Channels in hiPSC-Derived Cardiomyocytes

Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy

Mybpc3 gene therapy for neonatal cardiomyopathy enables long-term disease prevention in mice

Comparison of the effects of a truncating and a missense MYBPC3 mutation on contractile parameters of engineered heart tissue

Generation of a patient-specific hiPS cell line with heterozygous GNB2 mutation (UKMi003-A) causative for human sinus node dysfunction and a corresponding CRISPR/Cas9-corrected isogenic control (UKMi004-A)

Endothelin‐1 Induces Myofibrillar Disarray and Contractile Vector Variability in Hypertrophic Cardiomyopathy–Induced Pluripotent Stem Cell–Derived Cardiomyocytes

Nonsense-Mediated mRNA Decay and Ubiquitin–Proteasome System Regulate Cardiac Myosin-Binding Protein C Mutant Levels in Cardiomyopathic Mice

Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes

MYBPC3 in hypertrophic cardiomyopathy: from mutation identification to RNA-based correction

Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic Cardiomyopathy

Disease modeling of a mutation in α‐actinin 2 guides clinical therapy in hypertrophic cardiomyopathy

Analysis of Contractile Function of Permeabilized Human Hypertrophic Cardiomyopathy Multicellular Heart Tissue

Atrogin-1 and MuRF1 regulate cardiac MyBP-C levels via different mechanisms

Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy

Adrenergic stress reveals septal hypertrophy and proteasome impairment in heterozygous Mybpc3-targeted knock-in mice

ACTN2 Mutant Causes Proteopathy in Human iPSC-Derived Cardiomyocytes

Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology

Gene therapy strategies in the treatment of hypertrophic cardiomyopathy

Effects of Chronic Atrial Fibrillation on Active and Passive Force Generation in Human Atrial Myofibrils

Repair of Mybpc3 mRNA by 5′-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy

BSE-associated prion-amyloid cardiomyopathy in primates

Local Chromatin Mobility is Independent of Transcriptional Activity

The W101C IKCNJ5/I Mutation Induces Slower Pacing by Constitutively Active GIRK Channels in hiPSC-Derived Cardiomyocytes

Suchergebnisse filtern